Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

被引：0
|
作者：
Henk van der Poel
Laurence Klotz
Gerald Andriole
Abdel-Rahmène Azzouzi
Anders Bjartell
Olivier Cussenot
Freddy Hamdy
Markus Graefen
Paolo Palma
Arturo Rodriguez Rivera
Christian G. Stief
机构：
[1] Netherlands Cancer Institute,Department of Urology
[2] University of Toronto,Division of Urology, Sunnybrook Health Science Centre
[3] Washington University St Louis,Division of Urology, Department of Surgery
[4] CHU d’Angers,Service d’Urologie
[5] Sahlgrenska Academy at the University of Gothenburg,Department of Urology, Institute of Clinical Sciences
[6] UPMC Univ Paris 06,Institute Universitaire de Cancerologie
[7] GRC-05,Nuffield Department of Surgical Sciences
[8] ONCOTYPE-Uro,Martini
[9] University of Oxford,Clinic Prostate Cancer Center
[10] University Medical Center Hamburg-Eppendorf,Department of Urology
[11] Universidade Estadual de Campinas,Department of Urology, Klinikum Großhadern, University Hospital Munich
[12] Hospital General Tlahuac,Großhadern
[13] Ludwig-Maximillians-University München,undefined
来源：
World Journal of Urology | 2015年 / 33卷
关键词：
Prostate cancer; Focal therapy; Active surveillance; Low risk; Intermediate risk; Consensus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [41] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Albers, Peter
    Wiegel, Thomas
    Schmidberger, Heinz
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Meisner, Christoph
    Wellek, Stefan
    Grozinger, Klaus
    Renner, Peter
    Burmester, Martin
    Schneider, Fried
    Stoeckle, Michael
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 65 - 72
  • [42] Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
    Sherer, Michael, V
    Leonard, Austin J.
    Nelson, Tyler J.
    Guram, Kripa
    De Moraes, Gustavo Rodrigues
    Javier-Desloges, Juan
    Kane, Christopher
    McKay, Rana R.
    Rose, Brent S.
    Bagrodia, Aditya
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 61 - 67
  • [43] IMMEDIATE FOCAL THERAPY VS. ACTIVE SURVEILLANCE OF LOCALIZED LOW-INTERMEDIATE RISK PROSTATE CANCER
    Barayan, Ghassan A.
    Hanley, James A.
    Aprikian, Armen G.
    Kassouf, Wassim
    Brimo, Fadi
    Begin, Louis R.
    Tanguay, Simon
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E721 - E722
  • [44] Active Surveillance-Is It Feasible for Intermediate-risk Localised Prostate Cancer?
    Mukherjee, Subhabrata
    Promponas, Ioannis
    Petrides, Neophytos
    Hossain, Dafader
    Abbaraju, Jayasimha
    Madaan, Sanjeev
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 17 - 24
  • [45] Are men with favorable intermediate-risk prostate cancer candidates for active surveillance?
    Raldow, Ann Caroline
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony Victor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [46] Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
    Blas, Leandro
    Shiota, Masaki
    Eto, Masatoshi
    [J]. CANCERS, 2022, 14 (17)
  • [47] Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?
    Masic, Selma
    Washington, Samuel L., III
    Carroll, Peter R.
    [J]. CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 231 - 237
  • [48] Making a case “against” focal therapy for intermediate-risk prostate cancer
    Paolo Gontero
    Giancarlo Marra
    Dogu Teber
    Shahrokh Shariat
    Selami Albayrak
    Rafael Coelho
    Simon Tanguay
    Badrinath Konety
    [J]. World Journal of Urology, 2021, 39 : 719 - 728
  • [49] Making a case "against" focal therapy for intermediate-risk prostate cancer
    Gontero, Paolo
    Marra, Giancarlo
    Teber, Dogu
    Shariat, Shahrokh
    Albayrak, Selami
    Coelho, Rafael
    Tanguay, Simon
    Konety, Badrinath
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (03) : 719 - 728
  • [50] Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis
    Rashid K. Sayyid
    John Z. Benton
    William C. Reed
    Phillip Woodruff
    Martha K. Terris
    Christopher J. D. Wallis
    Zachary Klaassen
    [J]. World Journal of Urology, 2023, 41 : 93 - 99
12345